(Press-News.org) WHAT:
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There was no elevated MACE risk for the other antiretroviral drugs included in the analysis. The findings will be presented at the 2024 International AIDS Conference (AIDS 2024) in Munich, Germany.
The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) enrolled 7,769 study participants with HIV from 12 countries that found daily use of a cholesterol-fighting statin drug reduced the risk of major adverse cardiovascular events, such as heart attacks and strokes by more than one third. The REPRIEVE study team also performed statistical analyses to assess whether select ARVs were associated with MACE risk among study participants, all of whom had low-to-moderate cardiovascular disease risk. The ARVs selected for analysis had previously been linked to cardiovascular risk and included abacavir, tenofovir, zidovudine, stavudine, and drugs from a class called protease inhibitors (PIs). All were taken as part of multi-drug ART regimens.
Overall, 22% of study participants reported prior exposure to abacavir, 86% to tenofovir, 49% to zidovudine or stavudine, and 47% to PIs. At study entry, 13% of participants were taking abacavir, 61% were taking tenofovir, 10% were taking zidovudine or stavudine, and 26% were taking PIs. In the investigators’ analyses, participants with prior and current use of abacavir had a 50% and 42% elevated risk of MACE, respectively, compared to participants with no abacavir exposure. Former or current use of other ARVs was not associated with any change in MACE risk, and the co-administration of common ARV drug classes as part of an ART regimen did not impact the elevated MACE risk among participants with current or prior abacavir exposure.
According to the authors, these findings align with previous studies that also identified an elevated cardiovascular disease risk associated with abacavir. They suggest that more research is needed to better understand the increased risk observed in this analysis, including how these findings should be considered in the context of known cardiovascular disease risk factors, such as dyslipidemia, diabetes and hypertension, for people with HIV.
More information about the REPRIEVE trial is available at ClinicalTrials.gov under identifier NCT02344290.
REFERENCE:
CJ Fichtenbaum et al. Abacavir is associated with elevated risk for cardiovascular events in the REPRIEVE trial. International AIDS Conference. Friday, July 26, 2024.
WHO:
Sarah Read, M.D., deputy director, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH is available to discuss this research.
CONTACT:
To schedule interviews, please contact NIAID News & Science Writing Branch, 301-402-1663, niaidnews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
A new publication from Opto-Electronic Sciences; DOI 10.29026/oes.2024.230051 , discusses control of light–matter interactions in two-dimensional materials with nanoparticle-on-mirror structures.
With the rapid development of high bit-rate wireless services driven by mobile internet, AI computing, high-definition videos, virtual reality/augmented reality (VAR) applications, and so on, the demand for wireless data rates has grown explosively in the past decades1, 2. Supporting such fast data rate at tens of Gbit/s pushes the carrier frequency to the THz (0.1-10 THz) ...
Researchers from North Carolina State University, University of Manitoba, Bern University of Applied Sciences, University of South Carolina, and California Baptist University published a new Journal of Marketing study that explores whether the onset of daylight saving time leads consumers to engage in unhealthy behaviors.
The study, forthcoming in the Journal of Marketing, is titled “Spring Forward = Fall Back? The Effect of Daylight Saving Time Change on Consumers’ Unhealthy Behavior” and is authored by Ramkumar Janakiraman, Harsha ...
Research awards are an integral part of the universal “prestige economy” in science, but do they incentivize greater transparency, inclusivity, and openness? This study uses cross-disciplinary data to explore the level of transparency of publicly available award descriptions and assessment criteria, asking whether such awards contribute to or propagate existing reproducibility crises and inequities in science.
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002715
Article ...
Oligodendrocytes are an important source of amyloid beta (Aβ) and play a key role in promoting neuronal dysfunction in Alzheimer’s disease (AD), according to a study published July 23, 2024 in the open-access journal PLOS Biology by Rikesh Rajani and Marc Aurel Busche from the UK Dementia Research Institute at University College London, and colleagues.
AD is a devastating neurodegenerative disorder affecting millions of people worldwide. Accumulation of Aβ – peptides consisting of 36 to 43 amino acids – ...
“In this study, we explore the potential of the three largest, publicly available DNA methylation datasets in dogs to identify signals of biological age.”
BUFFALO, NY- July 23, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 13, entitled, “Co-analysis of methylation platforms for signatures of biological aging in the domestic dog reveals previously unexplored confounding factors.”
Chronological age reveals the number of years an individual has lived since birth. By contrast, biological age varies between individuals of the same chronological ...
BINGHAMTON, N.Y. -- A research team led by faculty from Binghamton University, State University of New York has been exploring how mass layoffs and data breaches could be connected. Their theory: since layoffs create conditions where disgruntled employees face added stress or job insecurity, they are more likely to engage in risky behaviors that heighten the company’s vulnerability to data breaches.
The research, outlined in a paper titled “The Impacts of Layoffs Announcement on Cybersecurity Breaches,” was presented by Binghamton ...
Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However, the machines tend to be expensive, clunky and uncomfortable — resulting in many users giving up on using them.
High blood pressure is often linked with sleep apnea because the brain works harder to regulate blood flow and breathing during sleep. A recent study at the University of Missouri offers new insight into the underlying mechanisms within the brain contributing ...
Abu Dhabi, July 22, 2024: A team of researchers at NYU Abu Dhabi, led by Professor Sehamuddin Galadari, has discovered that the tumor suppressor protein Prostate apoptosis response-4 (Par-4) can cause a unique type of cell death called ferroptosis in human glioblastoma – the most common and aggressive type of brain tumor – while sparing healthy cells. This new understanding has the potential to inform the development of novel treatments for various hard-to-treat cancers and neurodegenerative diseases.
Ferroptosis is triggered by the iron-mediated production of reactive ...
(BOSTON) – Donald M. Lloyd-Jones, MD, ScM, has accepted the position of director of the Framingham Center for Population and Prevention Science, principal investigator of the Framingham Heart Study, and chief of the section of preventive medicine within the department of medicine at the Chobanian & Avedisian School of Medicine and Boston Medical Center, effective January 1, 2025.
Lloyd-Jones is the chair of preventive medicine and Eileen M. Foell Professor of Heart Research and professor of preventive medicine, medicine and pediatrics at Northwestern University. He previously served as senior associate dean for clinical and translational ...
A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2024.240064, discusses advanced phase-controlled 3D biochemical imaging.
Three-dimensional (3D) imaging provides deep insights into understanding of complex biological and biomedical systems, which offers far more detailed information than traditional 2D methods. A standout in this field is nonlinear optical microscopy, particularly coherent Raman Scattering (CRS) microscopy (e.g., coherent anti-Stokes Raman scattering (CARS) and ...
